Skip to content

3D US Guided Femoral Artery Access for TAVI

Three Dimensional Ultrasound Guided Femoral Access for Transcatheter Aortic Valve Implantation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04691245
Acronym
3D-US-TAVI
Enrollment
104
Registered
2020-12-31
Start date
2021-02-28
Completion date
2021-12-31
Last updated
2020-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Artery Injury, Ultrasound Therapy; Complications

Keywords

3D Ultrasound, vascular access, Transcatheter aortic valve implantation

Brief summary

Rationale: Bleeding and vascular complications of the femoral artery still account for significant morbidity and mortality in transcatheter aortic valve implantation procedures. Although steadily declining over the past years through smaller diameter devices and use of ultrasound, major complications still occur in 3-4 % of patients. Femoral access is often obtained using 2D US guidance already. New 3D US probes can aid in increasing anatomical awareness. This can improve first pass success during procedures. Furthermore, for new closure devices, entering the artery at a straight angle at precisely 12 o'clock probably reduces complications. Therefore, the investigators hypothesize improved real time needle guidance using three dimensional ultrasound can decrease procedure related complications.

Interventions

DEVICE3D US

3D US guided access to femoral artery

DEVICE2D US

2D US guided access to femoral artery

Sponsors

Eindhoven University of Technology
CollaboratorOTHER
Catharina Ziekenhuis Eindhoven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

randomized clinical trial with two arms

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Adult age (\>18 years) * Scheduled to undergo elective transcatheter aortic valve implantation with percutaneous access through the femoral artery * Written Informed consent

Exclusion criteria

* Unable to obtain informed consent * Vascular access via alternative approach (radial/subclavian) or surgical cutdown

Design outcomes

Primary

MeasureTime frameDescription
first pass successduring procedure/surgerysuccessful entry in femoral artery within one skinbreak and without needle redirections

Secondary

MeasureTime frameDescription
procedure timeduring procedure/surgerytime from puncturing skin until entry in femoral artery (in seconds)
total number of puncturesduring procedure/surgerynew skin breaks needed for completion of procedure
number of needle redirectionsduring procedure/surgerytotal number of needle withdrawals \>5mm but without needing new skin puncture
imaging timeduring procedure/surgerytime from putting probe on skin to start procedure (in seconds)
needle visualizationduring procedure/surgeryrated from good-adequate-poor
operator satisfactionduring procedure/surgerylikert scale 1-5 with 1 no satisfaction and 5 completely satisfied
12 o clock entryduring procedure/surgeryentrance to femoral artery at exactly 12 o clock (antero-medial)

Countries

Netherlands

Contacts

Primary ContactHarm Scholten, MD
harm.scholten@cze.nl0031402398500
Backup ContactArthur Bouwman, PhD
arthur.bouwman@cze.nl0031402398500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026